To: StockDung who wrote (2797 ) 10/25/2000 8:55:19 AM From: DanZ Read Replies (1) | Respond to The FDA governs the Homeopathic Pharmacopeia of the United States (HPUS), and since the active ingredient in Zicam is listed there, it is in effect FDA approved to the degree required. You can read all about the HPUS at hpus.com . The FTC governs claims that companies make in their advertising, labeling, etc., and Gum Tech is entitled to claim that Zicam reduces the duration of the common cold by 75% because they have two independent clinical studies to back it up, one of which was published recently in ENT Journal. Again you prove how little you know. In fact, you prove that you don't know anything. Your game is to short a stock, manipulate the price, and attack message boards on the Internet. Notice that knowledge of the company that you are jacking with isn't even part of the equation. If Gum Tech announces the results of the preventative clinical study for Zicam, and it shows that it prevents the common cold, you are going to learn how expensive ignorance can be.
